Summary
Peptide YY (PYY) orchestrates the functions of the gut and the pancreas by regulating growth, digestion and absorption. In addition to its physiological role, PYY exhibits immune and antitrophic properties in the pancreas by decreasing cytokine and amylase release. Although the exact mechanism(s) of action are still incompletely understood, PYY interacts at the acinar level with numerous intracellular transcription factors. In addition to ameliorating pancreatic inflammation, novel synthetic analogs of PYY have been developed that are potent inhibitors of pancreatic cancer proliferation, in vitro and in vivo. Additionally, PYY and its analogs have been shown to inhibit the growth of breast, esophagus, and gastric cancer in vitro. We, herein, plan to review some of the methods employed in the laboratory while investigating the utility of PYY in the treatment of inflammation and cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vona-Davis, L., Yu, A., Magabo, K., Evans, T., Jackson, B., Riggs, D., and McFadden, D. (2004) Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis J Am Coll Surg 199, 87–95
Rizvi, I.A., Robinson, K., McFadden, D.W., Riggs, D., Jackson, B.J., and Vona-Davis, L.(2006) Peptide YY Reverses TNF-α induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells J Surg Res 136, 25–30
Robinson, K.S., Vona-Davis, L., Riggs, D., Jackson, B., and McFadden, D.W. (2006) Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J J Am Coll Surg 202, 788–796
Kazanjian, K.K., Towfigh, S., and McFad-den, D.W. (2003) Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro J Surg Res 114, 95–99
Reed, K. and McFadden, D.W. (1997) Pep-tide YY reduced the mortality of necrotizing pancreatitis Gastroenterology 112, A476
Tito, J.M., Rudnicki, M., Jones, D., Alp-ern, H.D., and Gold, M.S.(1993) Peptide YY ameliorates cerulein-induced pancreatic injury in the rat Am J Surg 165, 690–696
Liu, C.D., Rongione, A.J., Garvey, L., Balas-ubramaniam, A., and McFadden, D.W. (1996) Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth Am J Surg 171, 192–196
Liu, C.D., Slice, L.W., Balasubramaniam, A., Walsh, J.H., Newton, T.R., Saxton R.E., et al. (1995) Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels Surgery 118, 229–235
McFadden, D.W., Riggs, D.R., Jackson, B.J., and Vona-Davis, L. (2004) Peptide YY inhibits the growth of Barrett's esophageal adeno-carcinoma in vitro Am J Surg 188, 516–519
Yu, A., Somasundar, P., Balasubramaniam, A., Rose, A.T., Vona_Davis, L., and McFad-den, D.W. (2002) Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothe-lial growth factor J Surg Res 105, 65–68
Acknowledgments
The authors would like to thank Dale Riggs, Barbara Jackson, Linda Vona-Davis, PhD, and Debbie McDonald for their efforts.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Alosi, J.A., McFadden, D.W. (2009). Peptide YY Mediates Inhibition of Tumor Growth and Inflammation. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_22
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols